ALDX

Aldeyra Therapeutics, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Brady Todd CDirector, Officer: President And CEO
$418k250k shares
BuyJun 3, 2026
$1.67
--
Douglas RichardDirector
$98k70k shares
BuyMar 19, 2026
$1.40
--
Alfieri MichaelPrincipal Financial Officer
$7.1k5k shares
BuyMar 18, 2026
$1.42
--
Alfieri MichaelPrincipal Financial Officer
$13k2.5k shares
BuyAug 13, 2025
$5.30
--
Machatha StephenChief Development Officer
$114k22.1k shares
SellAug 11, 2025
$5.15
--
Perceptive Advisors LLC10 Percent Owner
$4.8M3.4M shares
SellApr 3, 2025
$1.42
--

News

gurufocus.comAldeyra Therapeutics Appoints Darlene Deptula-Hicks to Board of Directorsgurufocus.comJun 9businesswire.comAldeyra Therapeutics Appoints Darlene Deptula-Hicks to Board of Directorsbusinesswire.comJun 9marketbeat.comAldeyra Therapeutics Eyes FDA Feedback as Dry Eye Drug Faces Make-or-Break Momentmarketbeat.comJun 4businesswire.comAldeyra Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conferencebusinesswire.comJun 2newsfilecorp.comBronstein, Gewirtz & Grossman LLC Urges Aldeyra Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harmnewsfilecorp.comMay 29